Sempra (SRE) insider files Form 144 to sell 7,564 shares

Sempra (SRE) filed a notice under Rule 144 for a planned sale of 7,564 shares of its common stock through Oppenheimer & Co. on the NYSE, with an aggregate market value of $699,670.

Rhea-AI Filing Summary

Sempra (SRE) filed a notice under Rule 144 for a planned sale of 7,564 shares of its common stock through Oppenheimer & Co. on the NYSE, with an aggregate market value of $699,670. The filing notes that 652,681,521 shares of Sempra common stock were outstanding. The shares to be sold were acquired via vesting of restricted stock units under Sempra's Long-Term Incentive Plan, including 2,325 shares vested on 01/02/2025, 1,000 shares vested on 01/28/2025, and 4,239 shares vested on 02/19/2025, all received as equity compensation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Sempra (SRE)'s latest Form 144 filing disclose?

The Form 144 discloses a planned sale of 7,564 shares of Sempra common stock under Rule 144, with an aggregate market value of $699,670, to be sold on the NYSE.

How many Sempra (SRE) shares are planned to be sold and on which exchange?

The notice covers a proposed sale of 7,564 common shares of Sempra, expected to be sold on the New York Stock Exchange (NYSE).

What is the reported aggregate market value of the Sempra (SRE) shares in this Form 144?

The filing lists an aggregate market value of $699,670 for the 7,564 Sempra common shares covered by the planned Rule 144 sale.

How were the Sempra (SRE) shares in the Form 144 acquired?

The shares were acquired through vesting of restricted stock units under Sempra's Long-Term Incentive Plan, received as equity compensation on several vesting dates in 2025.

What portion of Sempra (SRE) shares is outstanding according to the Form 144?

The Form 144 states that 652,681,521 shares of Sempra common stock were outstanding at the time referenced in the filing.

When did the restricted stock units for Sempra (SRE) vest for the shares being sold?

The filing lists vesting dates of 01/02/2025 for 2,325 shares, 01/28/2025 for 1,000 shares, and 02/19/2025 for 4,239 shares, all as compensation awards.

Which broker is handling the planned Sempra (SRE) share sale under Rule 144?

The planned sale of 7,564 Sempra common shares is to be executed through Oppenheimer & Co., Inc. at its Los Angeles, California office.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/24/2025 - 05:03 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001851750
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SEMPRA
SEC File Number	001-14201
Address of Issuer	488 8TH AVENUE SAN DIEGO CALIFORNIA 92101
Phone	6196962000
Name of Person for Whose Account the Securities are To Be Sold	Sedgwick Karen L
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Oppenheimer & Co., Inc. 10880 Wilshire Boulevard Los Angeles CA 90024	7564	699670.00	652681521	11/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/02/2025	Vesting of grant of restricted stock units under Sempra's Long-Term Incentive Plan	Sempra			2325	01/02/2025	Vesting of equity award received as compensation
Common Stock	01/28/2025	Vesting of grant of restricted stock units under Sempra's Long-Term Incentive Plan	Sempra			1000	01/28/2025	Vesting of equity award received as compensation
Common Stock	02/19/2025	Vesting of grant of restricted stock units under Sempra's Long-Term Incentive Plan	Sempra			4239	02/19/2025	Vesting of equity award received as compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The shares of common stock reflected in this Form 144 are sold in accordance with a written instruction and plan for trading securities established by Ms. Sedgwick on August 19, 2025 pursuant to Rule 10b5-1(c) under the Securities Exchange Act of 1934.
Date of Notice	11/24/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	KAREN L. SEDGWICK BY: Lisa H. Abbot, Managing Attorney - Corporate and Securities of Sempra and Attorney-In-Fact
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)